![James Peyer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Peyer
Directeur/Membre du Conseil chez Aeonian Pharmaceuticals, Inc.
Postes actifs de James Peyer
Sociétés | Poste | Début | Fin |
---|---|---|---|
Aeonian Pharmaceuticals, Inc.
![]() Aeonian Pharmaceuticals, Inc. BiotechnologyHealth Technology Aeonian Pharmaceuticals, Inc. operates as a an R&D-stage biopharmaceutical company. It discovers, develops and commercializes innovative therapeutics for the treatment of rare and age-related diseases. The company is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | - | - |
Vita Therapeutics, Inc.
![]() Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | Directeur/Membre du Conseil | - | - |
Historique de carrière de James Peyer
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Director/Board Member | 2 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Aeonian Pharmaceuticals, Inc.
![]() Aeonian Pharmaceuticals, Inc. BiotechnologyHealth Technology Aeonian Pharmaceuticals, Inc. operates as a an R&D-stage biopharmaceutical company. It discovers, develops and commercializes innovative therapeutics for the treatment of rare and age-related diseases. The company is headquartered in San Francisco, CA. | Health Technology |
Vita Therapeutics, Inc.
![]() Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | Health Technology |
- Bourse
- Insiders
- James Peyer
- Expérience